论文部分内容阅读
本文用国产FT—647型骨密度仪测定了108例初诊甲亢患者的桡骨骨密度(Bone Mineral Density.简称BMD).结果:(1)本组桡骨BMD减低发生率为24.05％;(2)病程≥1年组和病程<1年组桡骨BMD减低发生率分别为31.92％和18.52％,前者明显高于后者(P<0.01);(3)T_3≥Gag/ml组和T_3<5ng/ml组桡骨BMD减低发生率分别为26.42％和21.82％,前者虽稍高于后者.但差异无显著性意义(P>0.05).本结果表明甲亢对骨质改变有重要影响,病程是造成甲亢患者骨矿物丢失的主要因素.
In this paper, Bone Mineral Density (BMD) of 108 newly diagnosed patients with hyperthyroidism was measured by the domestic FT-647 bone mineral density meter.Results: (1) The incidence of BMD decrease was 24.05% The incidence of radial BMD reduction in ≥1 year group and disease course <1 year group were 31.92% and 18.52% respectively, the former was significantly higher than the latter (P <0.01); (3) T_3≥Gag / ml group and T_3 <5ng / ml The BMD reduction rate of group BMD was 26.42% and 21.82% respectively, although the former was slightly higher than the latter, but the difference was not significant (P> 0.05) .This result shows that hyperthyroidism has an important effect on bone changes and the course of disease is hyperthyroidism The main cause of bone mineral loss in patients.